Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study.

IF 1.4 Q4 ONCOLOGY Pleura and Peritoneum Pub Date : 2023-03-01 DOI:10.1515/pp-2022-0133
Diane Charleux-Muller, Thibaut Fabacher, Benoit Romain, Nicolas Meyer, Cécile Brigand, Jean-Baptiste Delhorme
{"title":"Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study.","authors":"Diane Charleux-Muller,&nbsp;Thibaut Fabacher,&nbsp;Benoit Romain,&nbsp;Nicolas Meyer,&nbsp;Cécile Brigand,&nbsp;Jean-Baptiste Delhorme","doi":"10.1515/pp-2022-0133","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Current recommendations regarding enhanced recovery programs (ERPs) after complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are based on a low level of evidence. The aim of this study is to evaluate the effect of implementing an adapted ERP for CCRS and HIPEC in a referral center.</p><p><strong>Methods: </strong>We conducted a study with a prospective group of 44 patients (post-ERP group) who underwent CCRS with HIPEC between July 2016 and June 2018, the period during which ERP was implemented. This group was compared to a second retrospective group of 21 patients who underwent CCRS with HIPEC between June 2015 and June 2016, during which ERP was not yet implemented (pre-ERP group).</p><p><strong>Results: </strong>The ERP compliance rate was 65% in the post-ERP group. The hospital length of stay (HLS) was shorter in the post-ERP group: 24.9 days (IQR 11-68, pre-ERP group) vs. 16.1 days (IQR 6-45, post-ERP group), as was the major morbidity rate (pre-ERP group=33.3% vs. post-ERP group=20.5%). The nasogastric tube, urinary catheter and abdominal drains were all retrieved faster in the post-ERP group.</p><p><strong>Conclusions: </strong>The implementation of an adapted ERP after CCRS with HIPEC procedures reduces morbidity and shortens the HLS.</p>","PeriodicalId":20231,"journal":{"name":"Pleura and Peritoneum","volume":"8 1","pages":"11-18"},"PeriodicalIF":1.4000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067553/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pleura and Peritoneum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/pp-2022-0133","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Objectives: Current recommendations regarding enhanced recovery programs (ERPs) after complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are based on a low level of evidence. The aim of this study is to evaluate the effect of implementing an adapted ERP for CCRS and HIPEC in a referral center.

Methods: We conducted a study with a prospective group of 44 patients (post-ERP group) who underwent CCRS with HIPEC between July 2016 and June 2018, the period during which ERP was implemented. This group was compared to a second retrospective group of 21 patients who underwent CCRS with HIPEC between June 2015 and June 2016, during which ERP was not yet implemented (pre-ERP group).

Results: The ERP compliance rate was 65% in the post-ERP group. The hospital length of stay (HLS) was shorter in the post-ERP group: 24.9 days (IQR 11-68, pre-ERP group) vs. 16.1 days (IQR 6-45, post-ERP group), as was the major morbidity rate (pre-ERP group=33.3% vs. post-ERP group=20.5%). The nasogastric tube, urinary catheter and abdominal drains were all retrieved faster in the post-ERP group.

Conclusions: The implementation of an adapted ERP after CCRS with HIPEC procedures reduces morbidity and shortens the HLS.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在转诊中心实施完全细胞减少手术和腹腔内热化疗的增强恢复计划:一项病例对照前瞻性研究。
目的:目前关于完全细胞减少手术(CCRS)和腹腔热化疗(HIPEC)后增强恢复计划(ERPs)的建议是基于低水平的证据。本研究的目的是评估在转诊中心对CCRS和HIPEC实施适应性ERP的效果。方法:我们对2016年7月至2018年6月实施ERP期间接受CCRS合并HIPEC的44例患者(ERP后组)进行了一项前瞻性研究。将该组与2015年6月至2016年6月期间接受CCRS合并HIPEC的21例患者(ERP前组)进行比较。结果:ERP后组ERP依从率为65%。erp后组的住院时间(HLS)较短:24.9天(IQR 11-68, erp前组)比16.1天(IQR 6-45, erp后组),主要发病率较短(erp前组=33.3%,erp后组=20.5%)。erp后组鼻胃管、导尿管、腹腔引流管均恢复较快。结论:HIPEC CCRS术后应用适应性ERP可降低发病率,缩短HLS。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.50
自引率
11.10%
发文量
23
审稿时长
9 weeks
期刊最新文献
Combined Nabpaclitaxel pressurized intraPeritoneal aerosol chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic cancer peritoneal metastases: protocol of single-arm, open-label, phase II trial (Nab-PIPAC trial). Thromboelastogram changes are associated with postoperative complications after cytoreductive surgery. Impact of laparoscopic ultrasound during PIPAC directed treatment of unresectable peritoneal metastasis. In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different oxaliplatin-based HIPEC regimens. Ascites does not accompany pleural effusion developing under dasatinib therapy in patients with CML-CP.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1